Literature DB >> 17430825

Adverse effects of opioids on the central nervous systems of palliative care patients.

Jane Vella-Brincat1, A D Macleod.   

Abstract

Opioids, defined as drugs that stimulate opioid receptors, are primarily used in the treatment of moderate to severe pain. They induce central nervous system (CNS) adverse effects which can be divided into three groups. The first group includes effects that lower the level of consciousness-sedation, drowsiness and sleep disturbance. The second group affects the thinking process and the ability to react-cognitive impairment, psychomotor impairment, delirium, hallucinations, dreams and nightmares. The third group is of the direct toxic effects of opioids on neurons and includes myoclonus (perhaps), hyperalgesia and tolerance. This review addresses the incidence, possible mechanisms, and treatment of each of these groups of opioid-induced adverse effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17430825

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  26 in total

1.  Multiple opioids in pain management.

Authors:  Romayne Gallagher
Journal:  Can Fam Physician       Date:  2007-12       Impact factor: 3.275

2.  Preventability of adverse effects of analgesics: analysis of spontaneous reports.

Authors:  Irina Cazacu; Ghada Miremont-Salamé; Cristina Mogosan; Annie Fourrier-Réglat; Felicia Loghin; Françoise Haramburu
Journal:  Eur J Clin Pharmacol       Date:  2015-03-05       Impact factor: 2.953

3.  Sleep problems in advanced disease .

Authors:  Andrew Davies
Journal:  Clin Med (Lond)       Date:  2019-07       Impact factor: 2.659

Review 4.  Neurotoxicology Syndromes Associated with Drugs of Abuse.

Authors:  Rachel A Caplan; Jonah P Zuflacht; Jed A Barash; Corey R Fehnel
Journal:  Neurol Clin       Date:  2020-11       Impact factor: 3.806

Review 5.  Clinical Perspective on Opioids in the Context of Suicide Risk.

Authors:  Paul S Nestadt; Amy S B Bohnert
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

Review 6.  Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapy.

Authors:  Daniel E Spratt; Mayuko Sakae; Nadeem Riaz; Benjamin H Lok; Samuel Essandoh; Meier Hsu; Zhigang Zhang; Karen Schupak; Jeremy Setton; Nancy Y Lee
Journal:  Oncologist       Date:  2012-03-07

Review 7.  Pharmacoeconomic impact of adverse events of long-term opioid treatment for the management of persistent pain.

Authors:  Lieven Annemans
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

8.  [Pain therapy in patients with schizoaffective disorder and cancer].

Authors:  M Brinkers; G Pfau; A Voigt; C Schneemilch
Journal:  Schmerz       Date:  2015-04       Impact factor: 1.107

Review 9.  Pancreas Cancer-Associated Pain Management.

Authors:  Andrew L Coveler; Jonathan Mizrahi; Bory Eastman; Smith Jim Apisarnthanarax; Shalini Dalal; Terry McNearney; Shubham Pant
Journal:  Oncologist       Date:  2021-05-12

Review 10.  Are treatments more effective than placebos? A systematic review and meta-analysis.

Authors:  Jeremy Howick; Claire Friedemann; Maria Tsakok; Robert Watson; Teresa Tsakok; Jennifer Thomas; Rafael Perera; Susannah Fleming; Carl Heneghan
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.